Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma

Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) represents a rare tumor entity with limited treatment options and usually rapid tumor progression in case of metastatic disease. As further treatment options are needed and ACC metastases are sensitive to external beam radiation, novel theranostic approaches could comp...

Full description

Bibliographic Details
Main Authors: Kerstin Michalski, Wiebke Schlötelburg, Philipp E. Hartrampf, Aleksander Kosmala, Andreas K. Buck, Stefanie Hahner, Andreas Schirbel
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Pharmaceuticals
Subjects:
adrenocortical carcinoma
theranostics
endoradiotherapy
IMAZA
Online Access:https://www.mdpi.com/1424-8247/17/1/25

Internet

https://www.mdpi.com/1424-8247/17/1/25

Similar Items